{
Charles Witherspoon

People

}
West Pharmaceutical Services Upgraded to Buy with New Price Target of 390 Dollars
West Pharmaceutical Services (NYSE:WST) was upgraded by UBS Group from "neutral" to "buy," with a new price target of $390, indicating a potential upside of 22.63%. The company reported Q3 earnings of $1.85 per share, surpassing estimates, with revenue of $746.9 million, slightly down from the previous year. Insiders and institutional investors have recently adjusted their holdings, with institutional ownership at 93.90%.
MarketBeat
West Pharmaceutical Services, Inc. USA Charles Witherspoon
TradFi, Market Report
15:28 12.12.2024
west pharmaceutical services upgraded to buy with new price target of 390 dollars
West Pharmaceutical Services (NYSE:WST) was upgraded by UBS Group from "neutral" to "buy," with a price target raised to $390, indicating a potential upside of 22.63%. The company reported Q3 earnings of $1.85 per share, surpassing estimates, despite a slight revenue decline year-over-year. Insiders and institutional investors have recently adjusted their holdings, with institutional ownership at 93.90%.
MarketBeat
West Pharmaceutical Services, Inc. USA Charles Witherspoon
Finance & Economy, Market Report
15:28 12.12.2024
Trending
Subcategory:
Cryptocurrency Markets Stock Market Updates Cryptocurrency Trends Market Sentiment Analysis Central Bank Actions Decentralized Finance (DeFi) Innovations Banking Regulations Tokenomics and Crypto Economics Cryptocurrency & Blockchain Regulations Market Analysis and Predictions Cryptocurrency Regulations Corporate Responsibility & ESG Cryptocurrency Developments Blockchain Technology Adoption ESG & Sustainable Finance Regulations Inflation Rates & CPI Data Anti-Money Laundering (AML) Regulations SEC & Financial Compliance Real Estate Investments GDP Growth & Recession Forecasts
Countries:
USA CHE CHN JPN GBR RUS DEU KOR HKG FRA SGP AUS ARE IND CAN AUT ITA SLV ESP BRA
Companies:
BlackRock, Inc. Chainlink USD Coinbase Global, Inc. Fidelity Contrafund Aave USD UBS Group AG MicroStrategy Inc NVIDIA Corporation Apple Inc. Kraken Energy Corp. Solana USD Ethereum USD Tesla, Inc. Credit Suisse High Yield Bond Fund, Inc. Bitwise Bitcoin ETF Grayscale Litecoin Trust Ripples USD Google Inc. End Federal Reserve USD Nasdaq 100 Mar 25
Currencies:
United States Dollar Euro Japanese Yen Swiss Franc British Pound Sterling Chinese Yuan Hong Kong Dollar South Korean Won Indian Rupee Singapore Dollar Turkish Lira Armenian Dram Australian Dollar Somali Shilling Bulgarian Lev Czech Koruna Mongolian Tögrög Canadian Dollar
People:
Donald Trump Ali Martinez Paul Atkins Elon Musk Justin Sun Michael J. Saylor Gary Gensler David O. Sacks Jerome Powell Nayib Bukele Charles Hoskinson Eric Balchunas Vladimir Putin Oleg Deripaska Johann Strobl Yoon Suk Yeol Nate Geraci Beat Schmid Colm Kelleher Javon Marks

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.